Dr. Larson had spent over 20 years in the pharmaceutical industry beginning as a formulation scientist and more recently serving in leadership roles overseeing research and development related departments, including product development, analytical development, validation, quality assurance, and quality control. He has contributed to the development of multiple drug candidates and is an inventor on multiple U.S. and international patents. Dr. Larson’s areas of expertise include: oral solid dosage form development, small molecule parenteral drug product development, lipid-based formulations, modified and extended-release formulations, amorphous solid dispersions, pre-formulation and drug substance characterization, solid form (polymorph and pharmaceutical salt) screening and selection, manufacturing process development, analytical method development and validation, process validation, authoring/reviewing regulatory documents (INDs/NDAs), and overall strategic CMC support. Dr. Larson received a B.S. in Chemistry and a Ph.D. in Pharmaceutics and Pharmaceutical Chemistry from the University of Utah, where he currently teaches a graduate level course in Pharmaceutical Drug Product Development.